Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04426162 · ClinicalTrials.gov registry record · NA
Effects of Memory Boot Camp on Brain Function in Adults With Symptoms of Mild Cognitive Impairment (MCI)
A NA study of Mild Cognitive Impairment, sponsored by Neurocore.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 3
- Study locations
NCT04426162: Completed NA study of Mild Cognitive Impairment, sponsored by Neurocore.
NCT04426162 is a NA study of Mild Cognitive Impairment that has completed, run by Neurocore. The registered enrollment target is 76 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04426162, a NA study of Mild Cognitive Impairment, has completed, sponsored by Neurocore.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective controlled clinical trial to determine the effects of a 12-week Memory Boot Camp (MBC) program on cognitive function in older adults with symptoms of Mild Cognitive Impairment.
Primary Outcome
The MoCA is a validated, brief assessment tool that measures MCI and is widely used. Individuals are scored on seven different domains: visuospatial/executive, naming, attention, language, abstraction, delayed recall, and orientation.
Conditions Studied
Interventions
- OTHER Multi-domain Intervention
Study Locations (3)
Florida
- Neurocore Brain Performance Center - Boca Raton
- Neurocore Brain Performance Center - Palm Beach Gardens
Michigan
- Neurocore Brain Performance Center - Grandville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2019-04-24 |
| Phase | NA |
What the finished NCT04426162 record still lists
NCT04426162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Multi-domain Intervention is the first listed.
NCT04426162 reports a single indexed study location in Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT04426162 about?
NCT04426162 is a clinical study titled "Effects of Memory Boot Camp on Brain Function in Adults With Symptoms of Mild Cognitive Impairment (MCI)". This is a prospective controlled clinical trial to determine the effects of a 12-week Memory Boot Camp (MBC) program on cognitive function in older adults with symptoms of Mild Cognitive Impairment.
What is the current status of trial NCT04426162?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2017-10-05. Estimated completion is 2019-04-24.
What conditions does trial NCT04426162 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment.
What interventions are being tested in trial NCT04426162?
The interventions under investigation include: Multi-domain Intervention (OTHER).
Who is sponsoring clinical trial NCT04426162?
This trial is sponsored by Neurocore, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04426162 being conducted?
This trial has 3 study locations across Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04426162's enrollment target sits among peer trials
76 111th of 205 higher than 95 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI